Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Ent.it. Regulatory News (DNE)

  • This share is currently suspended. It was suspended at a price of 470.00

Share Price Information for Dunedin Ent.it. (DNE)

Share Price is delayed by 15 minutes
Get Live Data
470.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
DNE Live PriceLast checked at - London Stock Exchange

Intraday Dunedin Ent.it. Share Chart

Portfolio Update

29 Nov 2024 13:38

RNS Number : 2344O
Dunedin Enterprise Inv Trust PLC
29 November 2024
 

29 November 2024

Dunedin Enterprise Investment Trust PLC

Legal Entity Identifier: 213800E2VLUZ5AF9Z434

Realisation of EV Holdings Limited ("EV") and update on winding-up proposals

Dunedin Enterprise Investment Trust PLC ("DENT" or the "Company") is pleased to announce that regulatory approval has now been granted for the realisation of EV, a provider of high-performance video cameras and quantitative visual analytics to the global energy industry. The investment in EV is held via DENT's interest in Dunedin Buyout Fund III LP.

As at 30 September 2024 the Company's investment in EV was valued at £2.6m. Proceeds received from the transaction amount to £2.7m, consisting entirely of capital.

Following this realisation, the Company has remaining unlisted investments valued at £5.9m, cash balances of £26.8m and other net assets of £0.5m. As previously noted, the Company also has outstanding capital commitments to limited partnership funds of £6.9m.

Pursuant to its managed wind-down strategy, the Company's investment objective is to conduct an orderly realisation of its assets in a manner that seeks to achieve a balance between maximising the value of the Company's investments and progressively returning cash to shareholders. The Board and its advisers intend recommending to shareholders a members' voluntary liquidation of the Company. Any such winding-up will require shareholder approval and the Company intends to publish a circular to convene a general meeting shortly. A further announcement will be made imminently. 

For further information, please contact:

Dunedin LLP (Secretary) 

Graeme Murray

07813138367

 

Important Information

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended ("UK MAR") and is disclosed in accordance with the Company's obligations under UK MAR. Upon the publication of this announcement, this inside information will be considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUFLFVVLSLAFIS
Date   Source Headline
29th Jan 20251:17 pmRNSStatement re First Distribution in Liquidation
6th Jan 20252:48 pmRNSResult of General Meeting
30th Dec 20245:30 pmRNSDunedin Enterprise Investment Trust
19th Dec 20243:38 pmRNSGM - Announcement of Suspension Timetable
19th Dec 20243:27 pmRNSGM - Announcement of Suspension Timetable
9th Dec 20247:00 amRNSHolding(s) in Company
4th Dec 202410:00 amRNSPublication of Circular and Winding-up Timetable
4th Dec 202410:00 amRNSGeneral Meeting re: Member's Voluntary Liquidation
3rd Dec 20248:44 amRNSGeneral Meeting re: Member's Voluntary Liquidation
29th Nov 20241:38 pmRNSPortfolio Update
1st Nov 20247:00 amRNSPreliminary Unaudited Net Asset Value at 30/09/24
11th Sep 20247:00 amRNSHalf-year Report
27th Aug 20247:00 amRNSDividend Declaration
5th Aug 20247:00 amRNSPortfolio Update
1st Aug 20247:00 amRNSPreliminary unaudited net asset value at 30/6/24
15th May 20241:17 pmRNS1st Quarter Results
15th May 20241:12 pmRNSResult of AGM
7th May 20245:37 pmRNSHolding(s) in Company
1st May 20247:00 amRNSPreliminary Unaudited Net Asset Value at 31/3/24
22nd Mar 20247:00 amRNSAnnual Financial Report
5th Feb 20241:58 pmRNSHolding(s) in Company
5th Feb 20241:56 pmRNSHolding(s) in Company
5th Feb 20241:54 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/23
19th Dec 20232:34 pmRNSHolding(s) in Company
19th Dec 20232:22 pmRNSHolding(s) in Company
13th Dec 20237:00 amRNSDividend Declaration
21st Nov 20237:00 amRNSPremier Hytemp realisation & potential winding-up
16th Nov 20237:00 amRNS3rd Quarter Results
6th Nov 20234:33 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSPortfolio Update
1st Nov 20237:00 amRNSPreliminary Unaudited Net Asset Value at 30/9/23
28th Sep 20237:00 amRNSPortfolio Update
15th Sep 20237:00 amRNSHalf-year Report
1st Aug 20237:00 amRNSPreliminary unaudited net asset value at 30/6/23
6th Jun 20239:01 amRNSHolding(s) in Company
22nd May 202310:05 amRNSHolding(s) in Company
10th May 20232:42 pmRNSResult of AGM
10th May 20232:42 pmRNS1st Quarter Results
2nd May 20237:00 amRNSPreliminary unaudited net asset value at 31/3/23
24th Mar 20237:00 amRNSAnnual Financial Report
1st Feb 20237:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/22
7th Dec 20221:02 pmRNSDirector/PDMR Shareholding
7th Dec 20221:00 pmRNSDirector/PDMR Shareholding
7th Dec 20221:00 pmRNSDirector/PDMR Shareholding
6th Dec 202211:12 amRNSDirector/PDMR Shareholding
6th Dec 202211:09 amRNSDirector/PDMR Shareholding
1st Dec 202212:42 pmRNSHolding(s) in Company
30th Nov 20225:50 pmRNSDirector/PDMR Shareholding
30th Nov 20225:48 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.